Medical News

RSS

Fourteen cases identified on E. coli infection related to raw milk consumption in Connecticut

Raw milk is consumed by an estimated 1-3 percent of the United States population. Raw milk and raw cheeses are responsible for almost 70 percent of reported dairy outbreaks. On July 16, 2008, the Connecticut Department of Public Health identified two unrelated children who had experienced hemolytic uremic syndrome after consuming raw milk from the same farm. The authors investigated the situation further and found more cases of people affected by raw milk from the same farm.

3 Dec 2010

CDC: Hip replacement surgical procedures are more prevalent in the U.S.

According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.

3 Dec 2010

Indiana University to join multi-state program focused on cervical cancer prevention

Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation.

3 Dec 2010

MU nanomedicine experts form new partnership with Shasun Pharmaceuticals

University of Missouri leaders celebrated a nanomedicine milestone today as they announced the creation of a new drug development company. The new company forms a partnership between university researchers and an international pharmaceutical firm to advance testing of a potential cancer treatment created at MU.

3 Dec 2010

Justice Department offers expedited antitrust review for ACOs

Bloomberg: "Sharis Pozen, chief of staff of the [Justice] Department's antitrust division, told a House judiciary subcommittee" that "[t]he department intends to offer whatever guidance and clarity may be needed to ensure that providers pursue beneficial integrated ACOs without running afoul of the antitrust laws."

3 Dec 2010

Quebec Foundation invests $5 million for breast cancer research

Thanks to Quebecers' generosity and the many fundraising activities organized over the last two years, the Quebec Breast Cancer Foundation is proud to announce a new strategic funding competition, through which it will invest up to $5 million in Quebec for breast cancer research.

3 Dec 2010

EPO upholds Alnylam's Tuschl II 1407044 patent

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has fully upheld its Tuschl II '044 (EP 1407044) patent in oral opposition proceedings held in Munich. Specifically, the originally granted claims of the '044 patent were upheld without any modification and were deemed valid and supported by the EPO.

3 Dec 2010

Health costs: Employer-sponsored insurance premiums rise 41%

Premiums for employer-sponsored family health insurance increased an average of 41 percent across states from 2003 to 2009, more than three times faster than median incomes, and Maryland's rise was among the highest, at 50%, according to a report to be released Thursday by the Commonwealth Fund.

3 Dec 2010

Alcohol drinking pattern impacts coronary heart disease

A fascinating study published in the BMJ shows that although the French drink more than the Northern Irish each week, as they drink daily, rather than more on less occasions, the French suffered from considerably less coronary heart disease than the Northern Irish.

3 Dec 2010

Teva comments on Lovenox’s patent infringement lawsuit

Teva Pharmaceutical Industries Ltd. commented today on the patent infringement lawsuit filed by Momenta Pharmaceuticals, Inc. and Sandoz Inc.

3 Dec 2010

Medicare beneficiaries will need significant savings to cover health insurance costs in retirement

The Hill's Healthwatch blog: "Medicare beneficiaries of retirement age will need upwards of nearly $150,000 in savings to cover health insurance premiums and out-of-pocket expenses in order to have a 50-50 chance of being financially secure in retirement, according to a new report from the nonpartisan Employee Benefit Research Institute (EBRI).

3 Dec 2010

Scientists propose new effort to identify proteins in cancer cells

Scientists are proposing an international effort, on the scale of the Human Genome Project (HGP), to identify all the proteins present in cancer cells. HGP was the international scientific research project that identified and mapped all the genes in humans.

3 Dec 2010

Advanced Cell Technology eliminates $3 million in debt, strengthens balance sheet

Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.

3 Dec 2010

Study of proteins under jam-packed conditions may open new treatment for diseases

People in a jetliner act and feel one way when crammed together like sardines in a can. But they have quite a different mindset when the middle seat is empty and they have more personal space. Scientists are pursuing a remarkable parallel that exists among the proteins involved in health and disease inside living cells.

3 Dec 2010

Quitting smoking eases symptoms of depression

Quitting smoking is certainly healthy for the body, but doctors and scientists haven't been sure whether quitting makes people happier, especially since conventional wisdom says many smokers use cigarettes to ease anxiety and depression. In a new study, researchers tracked the symptoms of depression in people who were trying to quit and found that they were never happier than when they were being successful, for however long that was.

3 Dec 2010

Debt panel proposals target health costs

A White House-appointed commission's deficit-taming proposals would affect every corner of society. Workers with solid coverage on the job, seniors, drug companies, trial lawyers, hospitals, doctors, state governments and federal employees would all feel the effects.

3 Dec 2010

In spite of health care law, patients may still pay for preventive care

Minnesota Public Radio: In principal, the new federal healthcare law "requires insurers to cover preventive care — including colonoscopies, mammograms and immunizations at no cost to the patient — no co-pays, no deductibles." The aim is to encourage people to get preventive care before they develop conditions that are more costly to treat, and while "Medicare will begin covering these tests 100 percent on January 1st ... for other plans there are myriad exceptions.

3 Dec 2010

New inexpensive filtering technology to kill disease-causing bacteria in water

With almost one billion people lacking access to clean, safe drinking water, scientists are reporting development and successful initial tests of an inexpensive new filtering technology that kills up to 98 percent of disease-causing bacteria in water in seconds without clogging. A report on the technology appears in Nano Letters, a monthly American Chemical Society journal.

3 Dec 2010

AtriCure initiates enrollment in DEEP AF feasibility trial

AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

MHRA issues notice of acceptance for BioMarin's BMN 673 for genetically-defined cancers

BioMarin Pharmaceutical Inc. today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and has issued a notice of acceptance for BMN 673 for genetically-defined cancers.

3 Dec 2010